Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery
1980; Slack Incorporated (United States); Volume: 17; Issue: 1 Linguagem: Inglês
10.3928/0191-3913-19800101-06
ISSN1938-2405
Autores Tópico(s)Glycogen Storage Diseases and Myoclonus
ResumoBotulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery Alan B Scott, MD, , MD Alan B Scott, MD Journal of Pediatric Ophthalmology & Strabismus, 2013;17(1):21–25Published Online:January 01, 1980https://doi.org/10.3928/0191-3913-19800101-06Cited by:180PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore"Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery." Journal of Pediatric Ophthalmology & Strabismus, 17(1), pp. 21–251. Scott AB, Rosenbaum AL, Collins CC: Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12:924-927, 1973. Google Scholar2. Kelly RB, Deutsch JW, Carlson SS, et al: Biochemistry of neurotransmitter release. Ann Rev Neurosciences 2:399-446. Google Scholar3. Mukuno K: Personal communication, in Scott AB: Botulinum Toxin Injection of Eye Muscles (thesis, American Ophthalmology Society, 1979-1980, in preparation). Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Barbon C, Grünherz L, Schweizer R, Lindenblatt N and Giovanoli P (2022) Botulinum toxin to improve facial expression in a patient with Urofacial (Ochoa) Syndrome, American Journal of Medical Genetics Part A, 10.1002/ajmg.a.63025, 191:2, (559-563), Online publication date: 1-Feb-2023. Zhou K, Luo W, Liu T, Ni Y and Qin Z (2022) Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications, Toxins, 10.3390/toxins15010018, 15:1, (18) Rezazadeh F, Esnaashari N, Azad A and Emad S (2022) The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study, BMC Oral Health, 10.1186/s12903-022-02220-3, 22:1, Online publication date: 1-Dec-2022. GÜRBÜZ E and KAÇAR Z (2022) Botulinum Toksinin Gummy Smile Tedavisinde KullanımıUse of Botulinum Toxin in the Treatment of Gummy Smile, Sağlık Akademisi Kastamonu, 10.25279/sak.1134768 Calvisi L, Diaspro A and Sito G (2022) Microbotox: A prospective evaluation of dermatological improvement in patients with mild‐to‐moderate acne and erythematotelangiectatic rosacea, Journal of Cosmetic Dermatology, 10.1111/jocd.14692, 21:9, (3747-3753), Online publication date: 1-Sep-2022. Beck A, Paz L, Frank M, Engelmann A, Krause A and Côrte F (2022) Safety and Synovial Inflammatory Response After Intra-articular Injection of Botulinum Toxin Type A in Healthy Horses, Journal of Equine Veterinary Science, 10.1016/j.jevs.2022.103865, 110, (103865), Online publication date: 1-Mar-2022. Luton O, Mortimer M, Hopkins L, Robinson D, Egeler C, Smart N and Harries R (2022) Is there a role for botulinum toxin A in the emergency setting for delayed abdominal wall closure in the management of the open abdomen? A systematic review, The Annals of The Royal College of Surgeons of England, 10.1308/rcsann.2021.0284 Jabbari B (2022) The History of Botulinum Neurotoxin Development Botulinum Toxin Treatment of Pain Disorders, 10.1007/978-3-030-99650-5_1, (1-13), . Shi M, Zhou Y, Qin A, Cheng J and Ren H (2021) Treatment of acute acquired concomitant esotropia, BMC Ophthalmology, 10.1186/s12886-020-01787-1, 21:1, Online publication date: 1-Dec-2021. Brundridge W, Czyz C, Foster J, DeBacker C and Holck D (2021) Comparison of Prabotulinumtoxin A to Onabotulinumtoxin A in the Treatment of Lateral Canthal Rhytids: A Side-by-Side, Randomized, Double-Blind Comparison, The American Journal of Cosmetic Surgery, 10.1177/0748806821989882, 38:4, (259-266), Online publication date: 1-Dec-2021. An Y, Kim Y, Kim C, Yim H, Kim M, Lee E, Oh H, Han J, Yoo E, Kim S, Woo J, Moore E, Jung J and Park W (2021) Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain, Applied Microbiology and Biotechnology, 10.1007/s00253-021-11640-0, 105:23, (8727-8737), Online publication date: 1-Dec-2021. Watson N, Siddiqui Z, Miller B, Karagama Y and Gibbins N (2021) Non-aesthetic uses of botulinum toxin in the head and neck, European Archives of Oto-Rhino-Laryngology, 10.1007/s00405-021-06750-4, 278:11, (4147-4154), Online publication date: 1-Nov-2021. Rana A, Sthapit P, Limbu B, Amatya M and Saiju R (2021) Comparison of external dacryocystorhinostomy versus injection botulinum toxin in the management of functional epiphora, IP International Journal of Ocular Oncology and Oculoplasty, 10.18231/j.ijooo.2021.050, 7:3, (236-242), Online publication date: 28-Oct-2021. Qiao Z, Yang H, Jin L, Li S and Wang X (2021) The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis, Aesthetic Plastic Surgery, 10.1007/s00266-021-02196-5, 45:5, (2350-2362), Online publication date: 1-Oct-2021. Lai K, Tsang A, Kuk A, Ko C, Chan E and Ko S (2021) A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm, Neuro-Ophthalmology, 10.1080/01658107.2021.1916043, 45:5, (293-300), Online publication date: 3-Sep-2021. Dressler D, Pan L, Su J, Teng F and Jin L (2021) Lantox—The Chinese Botulinum Toxin Drug—Complete English Bibliography and Comprehensive Formalised Literature Review, Toxins, 10.3390/toxins13060370, 13:6, (370) Lai K, Kuk A, Chan E and Ko S (2020) The good toxin: 10 years of experience with botulinum toxin A in the treatment of benign essential blepharospasm, European Journal of Ophthalmology, 10.1177/1120672120925630, 31:3, (1345-1350), Online publication date: 1-May-2021. Esme P, Botsali A, Erbil H, Aksoy O and Caliskan E (2020) Bioactivity of abobotulinum toxin is preserved till 2 weeks upon storage at room temperature: Half body comparative study on rabbit model, Journal of Cosmetic Dermatology, 10.1111/jocd.13836, 20:5, (1367-1373), Online publication date: 1-May-2021. Núñez F, Mateos J and Núñez R (2021) Indicaciones médicas de la toxina botulínica, FMC - Formación Médica Continuada en Atención Primaria, 10.1016/j.fmc.2020.01.009, 28:2, (118-121), Online publication date: 1-Feb-2021. Choudhury S, Baker M, Chatterjee S and Kumar H (2021) Botulinum Toxin: An Update on Pharmacology and Newer Products in Development, Toxins, 10.3390/toxins13010058, 13:1, (58) Heckelmann J, Tapias D and Dafotakis M (2020) Botulinumtoxin in der NeurologieBotulinum toxin in neurology, DGNeurologie, 10.1007/s42451-020-00271-w, 4:1, (12-15), Online publication date: 1-Jan-2021. Goldschmidt M and Clemow J (2021) Neuromodulators (Botox) Applied Head and Neck Anatomy for the Facial Cosmetic Surgeon, 10.1007/978-3-030-57931-9_15, (123-129), . Ahuero A and Sires B (2021) Injectables and Fillers Smith and Nesi's Ophthalmic Plastic and Reconstructive Surgery, 10.1007/978-3-030-41720-8_21, (359-389), . Cho K, Heo J, Han J, Hong H, Jeon H, Hwang H, Hong C, Kim D, Han J and Baek K (2020) Industrial Applications of Dinoflagellate Phycotoxins Based on Their Modes of Action: A Review, Toxins, 10.3390/toxins12120805, 12:12, (805) Fung H, Chan K and Lam S (2020) A review on iatrogenic botulism, Hong Kong Journal of Emergency Medicine, 10.1177/1024907920934901, 27:6, (356-367), Online publication date: 1-Nov-2020. Diaspro A, Calvisi L, Manzoni V and Sito G (2020) Microbotulinum: A Quantitative Evaluation of Aesthetic Skin Improvement in 62 Patients, Plastic & Reconstructive Surgery, 10.1097/PRS.0000000000007248, 146:5, (987-994), Online publication date: 1-Nov-2020. Kaya B, Esen Bulut N and Fersahoglu M (2020) Is Intragastric Botulinum Toxin A Injection Effective in Obesity Treatment?, Surgery Research and Practice, 10.1155/2020/2419491, 2020, (1-4), Online publication date: 1-Oct-2020. Chang P, Jhou H, Chen P, Huang C, Chiang H, Chen K and Chang T (2020) Intragastric Botulinum Toxin A Injection Is an Effective Obesity Therapy for Patients with BMI > 40 kg/m2: a Systematic Review and Meta-analysis, Obesity Surgery, 10.1007/s11695-020-04842-4, 30:10, (4081-4090), Online publication date: 1-Oct-2020. BÜYÜKAFŞAR K (2020) Pharmacology of Botulinum Toxins: From Poison to Remedy, Düzce Tıp Fakültesi Dergisi, 10.18678/dtfd.777234 Tsui J (2020) Strategy for starting BoNT treatment (written consent, initial dose and subsequent doses, interval, follow-up), Toxicon, 10.1016/j.toxicon.2020.01.014, 176, (44-46), Online publication date: 1-Mar-2020. Hervochon R, Foirest C, Drouillard M and Tankéré F (2020) Toxine botulique dans le spasme hémifacial post-paralytique Le Nerf Facial : de la Paralysie Faciale à la Réhabilitation, 10.1016/B978-2-294-77444-7.00024-0, (281-289), . Youn J, Jang W and Park J (2020) Botulinum Toxin Injection in Hemifacial Spasm Hemifacial Spasm, 10.1007/978-981-15-5417-9_13, (119-126), . Jabbari B (2020) The History of Botulinum Neurotoxins: From 1820 to 2020 Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine, 10.1007/978-3-030-50691-9_1, (1-13), . Strey K (2019) Die Gifte‐Skala, Chemie in unserer Zeit, 10.1002/ciuz.201900828, 53:6, (386-399), Online publication date: 1-Dec-2019. Matak , Bölcskei , Bach-Rojecky and Helyes (2019) Mechanisms of Botulinum Toxin Type A Action on Pain, Toxins, 10.3390/toxins11080459, 11:8, (459) Markova E, Dubrovina K, Avakyants G and Malayan E (2019) Prospects for the Botulinum Toxin Use in the Treatment of Children`s Strabismus. Review, Ophthalmology in Russia, 10.18008/1816-5095-2019-2-163-168, 16:2, (163-168) Yang H and Jung J (2019) Diagnosis and treatment of childhood strabismus, Journal of the Korean Medical Association, 10.5124/jkma.2019.62.6.325, 62:6, (325), . Nobre M, Ciciarelli M and Souza J (2019) Botulinum Toxin for Migraine Daily Routine in Cosmetic Dermatology, 10.1007/978-3-319-20253-2_42-2, (1-8), . Nobre M, Ciciarelli M and Souza J (2019) Botulinum Toxin for Migraine Botulinum Toxins, Fillers and Related Substances, 10.1007/978-3-319-16802-9_42, (113-120), . Goldschmidt M and Clemow J (2019) Neuromodulators Office-Based Maxillofacial Surgical Procedures, 10.1007/978-3-030-22371-7_20, (313-324), . Whitcup S (2019) The History of Botulinum Toxins in Medicine: A Thousand Year Journey Botulinum Toxin Therapy, 10.1007/164_2019_271, (3-10), . Pero R, Laneri S and Fico G (2018) Botulinum Toxin Adverse Events Botulinum Toxin, 10.5772/intechopen.79761 Pittman P and Plotkin S (2018) Biodefense and Special Pathogen Vaccines Plotkin's Vaccines, 10.1016/B978-0-323-35761-6.00012-2, (149-160.e7), . Dinis P (2018) Botulinum Toxin in Treatment of Bladder Pain Syndrome/Interstitial Cystitis Bladder Pain Syndrome – An Evolution, 10.1007/978-3-319-61449-6_21, (101-104), . Nobre M, Ciciarelli M and Souza J (2018) Botulinum Toxin for Migraine Daily Routine in Cosmetic Dermatology, 10.1007/978-3-319-20253-2_42-1, (1-9), . Ma F, Zhai Z, Zhu S and Tang S (2017) Ultrastructural changes in human masseter muscles after botulinum neurotoxin a injection, Muscle & Nerve, 10.1002/mus.25609, 57:1, (96-99), Online publication date: 1-Jan-2018. Sánchez-Ramos J, Díaz-Benítez E, Hernández-Vázquez Á, Pérez-Montaño C, Rojas-Juárez S, Ramírez-Estudillo J and Zavaleta-Herrera F (2017) Inyección inadvertida de toxina botulínica subretiniana, Revista Mexicana de Oftalmología, 10.1016/j.mexoft.2017.05.004, 93:3, Online publication date: 15-Jun-2017. Kushner B (2017) Strabismus Surgery Strabismus, 10.1007/978-3-319-63019-9_10, (153-192), . Zendejas B and Zielinski M (2017) Botulinum Toxin Use in Complex Abdominal Wall Hernias Textbook of Hernia, 10.1007/978-3-319-43045-4_46, (361-365), . Trindade de Almeida A and Silva Y (2017) Botulinum Toxins Daily Routine in Cosmetic Dermatology, 10.1007/978-3-319-12589-3_32, (339-351), . Bomba-Warczak E, Vevea J, Brittain J, Figueroa-Bernier A, Tepp W, Johnson E, Yeh F and Chapman E (2016) Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons, Cell Reports, 10.1016/j.celrep.2016.06.104, 16:7, (1974-1987), Online publication date: 1-Aug-2016. Dressler D (2015) Botulinum toxin drugs: brief history and outlook, Journal of Neural Transmission, 10.1007/s00702-015-1478-1, 123:3, (277-279), Online publication date: 1-Mar-2016. de Almeida A and Silva Y (2016) Botulinum Toxins Daily Routine in Cosmetic Dermatology, 10.1007/978-3-319-20250-1_32-1, (1-13), . Benichou L, Labbe D, Le Louarn C and Guerreschi P (2015) Séquelles de paralysie faciale et toxine botulique, Annales de Chirurgie Plastique Esthétique, 10.1016/j.anplas.2015.07.011, 60:5, (377-392), Online publication date: 1-Oct-2015. Dressler D, Adib Saberi F, Kollewe K and Schrader C (2014) Safety aspects of incobotulinumtoxinA high-dose therapy, Journal of Neural Transmission, 10.1007/s00702-014-1252-9, 122:2, (327-333), Online publication date: 1-Feb-2015. Woodward J and Rao V (2015) Management of Benign Essential Blepharospasm Pearls and Pitfalls in Cosmetic Oculoplastic Surgery, 10.1007/978-1-4939-1544-6_139, (443-456), . Whitcup S, Turkel C, DeGryse R and Brin M (2014) Development of onabotulinumtoxinA for chronic migraine, Annals of the New York Academy of Sciences, 10.1111/nyas.12488, 1329:1, (67-80), Online publication date: 1-Nov-2014. Ibarra Hurtado T (2014) Toxina botulínica A: su importancia en pacientes con grandes hernias abdominales, Revista Hispanoamericana de Hernia, 10.1016/j.rehah.2014.05.003, 2:4, (131-132), Online publication date: 1-Oct-2014. Matak I and Lacković Z (2014) Botulinum toxin A, brain and pain, Progress in Neurobiology, 10.1016/j.pneurobio.2014.06.001, 119-120, (39-59), Online publication date: 1-Aug-2014. Hayashi M, Shimizu Y, Sato M, Yokoyama T and Yosimoto S (2014) Changes in the Blood Flow of the Femoral Artery by Botulinum Toxin A in Rats, Annals of Plastic Surgery, 10.1097/SAP.0b013e31826eabe3, 73:1, (98-101), Online publication date: 1-Jul-2014. Chaddock J (2014) Future Developments: Engineering the Neurotoxin Clinical Applications of Botulinum Neurotoxin, 10.1007/978-1-4939-0261-3_7, (177-192), . Foster K (2014) Overview and History of Botulinum Neurotoxin Clinical Exploitation Clinical Applications of Botulinum Neurotoxin, 10.1007/978-1-4939-0261-3_1, (1-5), . Chen S and Barbieri J (2014) Protease Activity of the Botulinum Neurotoxins Molecular Aspects of Botulinum Neurotoxin, 10.1007/978-1-4614-9454-6_8, (171-189), . Ahn B, Kim Y, Kim H, Rho N and Kim H (2013) Consensus Recommendations on the Aesthetic Usage of Botulinum Toxin Type A in Asians, Dermatologic Surgery, 10.1111/dsu.12317, 39:12, (1843-1860), Online publication date: 1-Dec-2013. George K, Kiani H and Witherow H (2013) Effectiveness of botulinum toxin B in the treatment of drooling, British Journal of Oral and Maxillofacial Surgery, 10.1016/j.bjoms.2013.05.154, 51:8, (783-785), Online publication date: 1-Dec-2013. Russell A, Kavia R, Dasgupta P and Sahai A (2013) The use of botulinum toxin for the treatment of urologic pain, Current Opinion in Urology, 10.1097/MOU.0b013e3283656a6b, 23:6, (570-578), Online publication date: 1-Nov-2013. Whitemarsh R, Tepp W, Bradshaw M, Lin G, Pier C, Scherf J, Johnson E, Pellett S and Bliska J (2013) Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, and In Vitro , Infection and Immunity, 10.1128/IAI.00536-13, 81:10, (3894-3902), Online publication date: 1-Oct-2013. Kim C, Jang W, Son I, Nam S, Kim Y, Park K, Kim B and Kim M (2013) Electrophysiological study for comparing the effect of biological activity between type A botulinum toxins in rat gastrocnemius muscle, Human & Experimental Toxicology, 10.1177/0960327113479044, 32:9, (914-920), Online publication date: 1-Sep-2013. Garcia-Ruiz P (2013) Aplicaciones de la toxina botulínica en Neurología, Medicina Clínica, 10.1016/j.medcli.2012.12.015, 141:1, (33-36), Online publication date: 1-Jul-2013. Oppenheimer A, Monson L and Buchman S (2013) Pediatric Orbital Fractures, Craniomaxillofacial Trauma & Reconstruction, 10.1055/s-0032-1332213, 6:1, (9-20), Online publication date: 1-Mar-2013. Giacometti J and Yen M (2013) Update on Botulinum Toxins in Oculofacial Plastic Surgery, International Ophthalmology Clinics, 10.1097/IIO.0b013e31828c0472, 53:3, (21-31), . Pittman P and Plotkin S (2013) Biodefense and special pathogen vaccines Vaccines, 10.1016/B978-1-4557-0090-5.00044-6, (1008-1017), . Souza-Dias C (2013) A vision of the present and future of strabismus Pediatric Ophthalmology and Strabismus, 10.1016/B978-0-7020-4691-9.00069-8, (721-725.e2), . Chen Y, Sun M, Hsueh P and Kao L (2012) Botulinum injection for the treatment of acute esotropia resulting from complete acute abducens nerve palsy, Taiwan Journal of Ophthalmology, 10.1016/j.tjo.2012.07.005, 2:4, (140-143), Online publication date: 1-Dec-2012. Chen S (2012) Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments, Toxins, 10.3390/toxins4100913, 4:10, (913-939) Pellett S (2012) Learning from the past: historical aspects of bacterial toxins as pharmaceuticals, Current Opinion in Microbiology, 10.1016/j.mib.2012.05.005, 15:3, (292-299), Online publication date: 1-Jun-2012. Dressler D (2012) Pharmakologie der BotulinumtoxinmedikamentePharmacology of botulinum toxin drugs, HNO, 10.1007/s00106-012-2494-1, 60:6, (496-504), Online publication date: 1-Jun-2012. Benecke R (2012) Clinical Relevance of Botulinum Toxin Immunogenicity, BioDrugs, 10.2165/11599840-000000000-00000, 26:2, (e1-e9), Online publication date: 1-Apr-2012. Lebeda F, Dembek Z and Adler M (2012) Kinetic and Reaction Pathway Analysis in the Application of Botulinum Toxin A for Wound Healing, Journal of Toxicology, 10.1155/2012/159726, 2012, (1-9), . (2012) Injections de toxine botulique (aspects techniques) Chirurgie Oculomotrice, 10.1016/B978-2-294-02142-8.00013-1, (263-268), . (2012) Actions chirurgicales correctrices Chirurgie Oculomotrice, 10.1016/B978-2-294-02142-8.00004-0, (69-84), . Chaddock J (2012) Transforming the Domain Structure of Botulinum Neurotoxins into Novel Therapeutics Botulinum Neurotoxins, 10.1007/978-3-642-33570-9_13, (287-306), . Ahuero A and Sires B (2012) Injectables and Fillers Smith and Nesi's Ophthalmic Plastic and Reconstructive Surgery, 10.1007/978-1-4614-0971-7_31, (473-500), . Trindade De Almeida A, Secco L and Carruthers A (2011) Handling Botulinum Toxins, Dermatologic Surgery, 10.1111/j.1524-4725.2011.02087.x, 37:11, (1553-1565), Online publication date: 1-Nov-2011. Kopera D (2011) Botulinum toxin historical aspects: from food poisoning to pharmaceutical, International Journal of Dermatology, 10.1111/j.1365-4632.2010.04821.x, 50:8, (976-980), Online publication date: 1-Aug-2011. Uibel S and Groneberg D (2014) Clostridium botulinum und seine Toxine: Krankheitserreger und potentielle Biowaffe?Clostridium botulinum and its toxins: pathogenic germ and potential biological weapon? Current aspects of the scientific knowledge, Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 10.1007/BF03346248, 61:4, (126-141), Online publication date: 1-Apr-2011. Bernat I, Sain-Oulhen C, Gatignol P, Lamas G and Tankéré F (2011) Traitement des séquelles des paralysies faciales par la toxine botulique Chirurgie Plastique Réparatrice De la Face et du Cou - Volume 1, 10.1016/B978-2-294-71189-3.00032-X, (365-372), . Dressler D (2011) Nonprimary dystonias Hyperkinetic Movement Disorders, 10.1016/B978-0-444-52014-2.00038-0, (513-538), . McLoon L (2011) The Extraocular Muscles Adler's Physiology of the Eye, 10.1016/B978-0-323-05714-1.00007-8, (182-207), . Keith F and John C (2010) Targeted Secretion Inhibitors—Innovative Protein Therapeutics, Toxins, 10.3390/toxins2122795, 2:12, (2795-2815) Lim E and Seet R (2010) Use of botulinum toxin in the neurology clinic, Nature Reviews Neurology, 10.1038/nrneurol.2010.149, 6:11, (624-636), Online publication date: 1-Nov-2010. Alter K (2010) High-Frequency Ultrasound Guidance for Neurotoxin Injections, Physical Medicine and Rehabilitation Clinics of North America, 10.1016/j.pmr.2010.05.001, 21:3, (607-630), Online publication date: 1-Aug-2010. Chapple C (2010) Complex Reconstructive Surgery Textbook of Female Urology and Urogynecology, Third Edition, 10.3109/9781439807217-103, (998-1022), Online publication date: 15-Jul-2010. Dressler D (2010) Botulinum toxin for treatment of dystonia, European Journal of Neurology, 10.1111/j.1468-1331.2010.03058.x, 17, (88-96) Orlova O, Soikher M, Soikher M, Mingazoval L, Kotlyrov V and Slavicek G (2010) Therapeutic application of Botulinum Toxin A in patients with local muscle dystonia and oral dyskinesia, international journal of stomatology & occlusion medicine, 10.1007/s12548-010-0042-8, 3:1, (23-28), Online publication date: 1-Mar-2010. Rittié L, Fisher G and Voorhees J (2010) Aging and Photoaging of the Skin Therapy of Skin Diseases, 10.1007/978-3-540-78814-0_60, (705-716), . Rowe F and Noonan C (2009) Complications of Botulinum Toxin A and Their Adverse Effects, Strabismus, 10.3109/09273970903303860, 17:4, (139-142), Online publication date: 1-Dec-2009. da Silva C and Cruz F (2009) Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?, Current Opinion in Urology, 10.1097/MOU.0b013e32832ae176, 19:4, (347-352), Online publication date: 1-Jul-2009. Lu D and Lippitz J (2009) Complications of Botulinum Neurotoxin, Disease-a-Month, 10.1016/j.disamonth.2009.01.001, 55:4, (198-211), Online publication date: 1-Apr-2009. Mulligan D and Bologna R (2009) Botulinum toxin: historical perspective and treatment of neurogenic and idiopathic overactive bladder, Therapy, 10.2217/14750708.6.2.165, 6:2, (165-175), Online publication date: 1-Mar-2009. Boyle M, McGwin G, Flanagan C, Vicinanzo M and Long J (2009) High Versus Low Concentration Botulinum Toxin A for Benign Essential Blepharospasm: Does Dilution Make a Difference?, Ophthalmic Plastic & Reconstructive Surgery, 10.1097/IOP.0b013e31819946c4, 25:2, (81-84), Online publication date: 1-Mar-2009. Dressler D, Truong D and Hallett M (2009) Developing the next generation of botulinum toxin drugs Manual of Botulinum Toxin Therapy, 10.1017/CBO9780511575761.026, (205-208) Roggenkaemper P and Scott A (2009) Botulinum toxin applications in ophthalmology Manual of Botulinum Toxin Therapy, 10.1017/CBO9780511575761.012, (77-84) Guyuron B and Becker D (2009) Surgical Management of Migraine Headaches Plastic Surgery: Indications and Practice, 10.1016/B978-1-4160-4081-1.50129-6, (1655-1665), . Chang S, Tsai H, Chen W, Lee W, Chen P and Tsai T (2008) The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A, International Journal of Dermatology, 10.1111/j.1365-4632.2008.03895.x, 47:12, (1287-1294), Online publication date: 1-Dec-2008. Barqawi A and Crawford E (2008) The role of botulinum toxin a in the management of lower urinary tract symptoms, Current Prostate Reports, 10.1007/s11918-008-0018-y, 6:3, (117-122), Online publication date: 1-Aug-2008. Dressler D (2008) Botulinum toxin drugs: future developments, Journal of Neural Transmission, 10.1007/s00702-007-0863-9, 115:4, (575-577), Online publication date: 1-Apr-2008. Grise P, Daoudi Y, Tanneau Y and Sibert L (2008) Principes d'action et indication de la toxine botulique dans le traitement de l'hyperactivité vésicale, EMC - Urologie, 10.1016/S1762-0953(06)75020-8, 1:1, (1-8), Online publication date: 1-Jan-2008. Pittman P and Plotkin S (2008) Biodefense and special pathogen vaccines Vaccines, 10.1016/B978-1-4160-3611-1.50044-1, (1123-1133), . Roy F (2008) ACQUIRED NONACCOMMODATIVE ESOTROPIA 378.00 Roy and Fraunfelder's Current Ocular Therapy, 10.1016/B978-1-4160-2447-7.50222-X, (403-404), . Dressler D (2007) Entwicklungsperspektiven von Botulinum-Toxin-MedikamentenCurrent outlook on botulinum toxin medications, Der Nervenarzt, 10.1007/s00115-007-2347-4, 78:12, (1444-1446), Online publication date: 1-Dec-2007. McNeer K and Tucker M (2014) Therapeutic application of botulinum toxin A in infantile esotropia, Expert Review of Ophthalmology, 10.1586/17469899.2.5.733, 2:5, (733-739), Online publication date: 1-Oct-2007. Partikian A and Mitchell W (2016) Iatrogenic Botulism in a Child With Spastic Quadriparesis, Journal of Child Neurology, 10.1177/0883073807306269, 22:10, (1235-1237), Online publication date: 1-Oct-2007. Karsenty G, Corcos J, Schurch B, Ruffion A and Chartier-Kastler E (2007) Chapitre C-l C - Traitement pharmacologique de l'hyperactivité détrusorienne neurologique : injections intra-détrusoriennes de toxine botulique A, Progrès en Urologie, 10.1016/S1166-7087(07)92370-2, 17:3, (568-575), Online publication date: 1-May-2007. Maas C (2007) Botulinum Neurotoxins and Injectable Fillers: Minimally Invasive Management of the Aging Upper Face, Otolaryngologic Clinics of North America, 10.1016/j.otc.2006.11.004, 40:2, (283-290), Online publication date: 1-Apr-2007. Dressler D and Benecke R (2009) Pharmacology of therapeutic botulinum toxin preparations, Disability and Rehabilitation, 10.1080/09638280701568296, 29:23, (1761-1768), Online publication date: 1-Jan-2007. Lim E and Seet R (2007) Botulinum toxin, Quo Vadis?, Medical Hypotheses, 10.1016/j.mehy.2007.03.019, 69:4, (718-723), Online publication date: 1-Jan-2007. Hamilton D (2007) Nonsurgical Facial Rejuvenation Master Techniques in Facial Rejuvenation, 10.1016/B978-1-4160-0146-1.50022-5, (261-273), . Maas C (2006) Botulinum Neurotoxins and Injectable Fillers: Minimally Invasive Management of the Aging Upper Face, Facial Plastic Surgery Clinics of North America, 10.1016/j.fsc.2006.05.002, 14:3, (241-245), Online publication date: 1-Aug-2006. Dressler D (2006) Pharmakologische Aspekte therapeutischer Botulinum-Toxin-PräparationenPharmacological aspects of therapeutic botulinum toxin preparations, Der Nervenarzt, 10.1007/s00115-006-2090-2, 77:8, (912-921), Online publication date: 1-Aug-2006. PATKI P, HAMID R, ARUMUGAM K, SHAH P and CRAGGS M (2006) Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury, BJU International, 10.1111/j.1464-410X.2006.06192.x, 98:1, (77-82), Online publication date: 1-Jul-2006. Merati A, Heman‐Ackah Y, Abaza M, Altman K, Sulica L and Belamowicz S (2016) Common Movement Disorders Affecting the Larynx: A Report from the Neurolaryngology Committee of the AAO‐HNS, Otolaryngology–Head and Neck Surgery, 10.1016/j.otohns.2005.05.003, 133:5, (654-665), Online publication date: 1-Nov-2005. Pidcock F (2009) Botulinum toxin type A treatment in neurogenetic syndromes, Pediatric Rehabilitation, 10.1080/13638490400022238, 8:4, (298-302), Online publication date: 1-Oct-2005. Grise P, Daoudi Y, Tanneau Y and Sibert L (2005) Principes d'action et indication de la toxine botulique dans le traitement de l'hyperactivité vésicale, Annales d'Urologie, 10.1016/j.anuro.2005.07.001, 39:3-4, (105-115), Online publication date: 1-Jun-2005. Mejia N, Vuong K and Jankovic J (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity, Movement Disorders, 10.1002/mds.20376, 20:5, (592-597), Online publication date: 1-May-2005. Clark R and Berris C (2005) Botulinum Toxin: A Treatment for Facial Asymmetry Caused by Facial Nerve Paralysis, Plastic and Reconstructive Surgery, 10.1097/01.PRS.0000150149.74749.55, 115:2, (573-574), Online publication date: 1-Feb-2005. Aoki K (2005) Pharmacology and Immunology of Botulinum Neurotoxins, International Ophthalmology Clinics, 10.1097/01.iio.0000167167.10402.74, 45:3, (25-37), Online publication date: 1-Oct-2006. Grise P, Daoudi Y, Tanneau Y and Sibert L (2005) Principios de acción e indicación de la toxina botulínica en el tratamiento de la hiperactividad vesical, EMC - Urología, 10.1016/S1761-3310(05)45035-5, 37:4, (1-8), Online publication date: 1-Jan-2005. Cornelia C, Simpson L and Jankovic J (2005) Botulinum Toxins: Transformation of a Toxin into a Treatment From Neuroscience To Neurology, 10.1016/B978-012738903-5/50008-4, (125-139), . Rohrich R, Janis J, Fagien S and Stuzin y (2004) Aplicaciones estéticas de la toxina botulínica, Plastic and Reconstructive Surgery, 10.1097/01.PRS.0000124433.01353.D7, 114:Supplement, (203S-215S), Online publication date: 1-Oct-2004. Batniji R and Falk A (2004) Update on botulinum toxin use in facial plastic and head and neck surgery, Current Opinion in Otolaryngology & Head and Neck Surgery, 10.1097/01.moo.0000131443.50445.53, 12:4, (317-322), Online publication date: 1-Aug-2004. Harper M, Fowler C and Dasgupta P (2004) Botulinum toxin and its applications in the lower urinary tract, BJU International, 10.1111/j.1464-410X.2003.04714.x, 93:6, (702-706), Online publication date: 1-Apr-2004. Baumann L and Halem M (2004) Botulinum toxin-B and the management of hyperhidrosis, Clinics in Dermatology, 10.1016/j.clindermatol.2003.11.001, 22:1, (60-65), Online publication date: 1-Jan-2004. Sesardic D, Leung T and Gaines Das R (2003) Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin, Biologicals, 10.1016/j.biologicals.2003.08.001, 31:4, (265-276), Online publication date: 1-Dec-2003. Rohrich R, Janis J, Fagien S and Stuzin J (2003) The Cosmetic Use of Botulinum Toxin, Plastic and Reconstructive Surgery, 10.1097/01.PRS.0000082208.37239.5B, 112:Supplement, (177S-188S), Online publication date: 1-Oct-2003. Mooney, J, Koman L and Smith B (2003) Pharmacologic Management of Spasticity in Cerebral Palsy, Journal of Pediatric Orthopaedics, 10.1097/01241398-200309000-00021, 23:5, (679-686), Online publication date: 1-Sep-2003. Mooney, J, Koman L and Smith B (2003) Pharmacologic Management of Spasticity in Cerebral Palsy, Journal of Pediatric Orthopaedics, 10.1097/00004694-2003
Referência(s)